When was QuadMedicine founded?

QuadMedicine was founded in 2016.

Where is QuadMedicine located?

QuadMedicine is headquartered in Seongnam-si, South Korea.

How many employees does QuadMedicine have?

As of Aug 31, 2026, the latest employee count at QuadMedicine is 5.

Is QuadMedicine a funded company?

QuadMedicine is a funded company, having raised a total of $11.7M across 4 funding rounds to date. The company's 1st funding round was a $***** Series B round.

When was the latest funding round of QuadMedicine?

QuadMedicine's latest funding was a $***** Series C round on May 11, 2022, with participation from 5 investors. Its primary sector is Drug Delivery. In South Korea, the Drug Delivery sector has seen $27M in funding in 2026 to date.

Where does QuadMedicine rank among its competitors?

QuadMedicine ranks 17th amongst 79 active competitors, of which 29 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was CeQur, which secured $100M in Jun, 2026.

Who are the top competitors of QuadMedicine?

QuadMedicine's top competitors include scPharmaceuticals, CeQur and Vaxxas. Among them, CeQur secured the most recent funding round in June, 2026.

QuadMedicine - 2026 Company Profile, Team, Funding & Competitors

QuadMedicine is a public company based in Seongnam-si (South Korea), founded in 2016. It operates as a Provider of patch for vaccine delivery. QuadMedicine has raised $11.7M in funding from investors like SparkLabs, Shinhan Venture Investment and Kwangdong Pharmaceutical. The company has 79 active competitors, including 29 funded and 13 that have exited. Its top competitors include companies like scPharmaceuticals, CeQur and Vaxxas.

Company Details

Website: quadmedicine.com
Email ID: *****@quadmedicine.com
Phone Number: +82 **********

Key Metrics

Founded Year

2016

Location

Seongnam-si, South Korea

Stage

Public

Total Funding

$11.7M in 4 rounds

Latest Funding Round

Series C, May 11, 2022, $*****

Investors

SparkLabs & 9 more

Ranked

17^th among 79 active competitors

Employee Count

5 as on Aug 31, 2026

Similar Companies

scPharmaceuticals & 100 more

Exit Details

Public

View QuadMedicine's full profile

QuadMedicine is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Quad Medison Co., Ltd. CIN: 313-81-33819 , South Korea, Active	Dec 22, 2016	-	-	-

QuadMedicine got listed on Dec 12, 2025.

Click here to take a look at QuadMedicine's IPO in detail

QuadMedicine has raised a total funding of $11.7M over 4 rounds. Its latest funding round was a Series C round on May 11, 2022 for $*****. 5 investors participated in its latest round. QuadMedicine has 10 institutional investors.

Here is the list of recent funding rounds of QuadMedicine:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 11, 2022	4184826	Series C	4133676	6375610	3989069	3427805
Nov 21, 2021	6702703	Seed	5110488	1785938	6714075	9367126
Jan 13, 2020	1070566	Seed	1201197	1411907	SparkLabs	8007516

Access funding benchmarks and valuations. Sign up today!

View details of QuadMedicine's funding rounds and investors

QuadMedicine's employee count trend

QuadMedicine has 5 employees as of Aug 26. Here is QuadMedicine's employee count trend over the years:

Uncover QuadMedicine's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of QuadMedicine include scPharmaceuticals, CeQur and Vaxxas. Here is the list of Top 10 competitors of QuadMedicine, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	scPharmaceuticals 2013, Lexington (United States), Acquired	Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure	$78.7M	Orbimed, Sun Pharma & 4 others	59/100
2nd	CeQur 2008, Horw (Switzerland), Series E	Developer of wearable insulin delivery patch	$492M	Endeavour Vision, Schroders & 7 others	59/100
3rd	Vaxxas 2010, Brisbane (Australia), Series D	Developer of a needle-free patch technology for vaccine delivery applications	$91.2M	One Ventures, UniQuest & 12 others	58/100
4th	Hero Patch 2019, Boston (United States), Series A	Developer of antibodies or small molecules for drug delivery	$20.5M	Big Pi Ventures, Velocity Partners & 5 others	55/100
5th	Starton 2017, New York City (United States), Seed	Developer of drug delivery solution and drugs for treating oncology	$9.29M	LOVE Pharma, Goldfingr	52/100
6th	Corsair Phama 2014, San Francisco (United States), Series B	Developer of drugs for the treatemnt of cardiac diseases	$23M	New Rhein, Primavera & 3 others	51/100
7th	Valeritas 2003, Bridgewater (United States), Acquired	Developer of wearable insulin patch pumps for insulin delivery through the skin	$231M	Welsh, Carson, Anderson & Stowe, Abingworth ... & 12 others	48/100
8th	AFYX Therapeutics 2013, Copenhagen (Denmark), Series A	Developer of drug patches for the treatment of mucosal diseases	$33.3M	Sofinnova Investments, Nordic Venture & 6 others	47/100
9th	Samyang BioPharm 2011, Seoul (South Korea), Funding Raised	Portfolio of drug loaded transdermal patches and wound closure medical devices	-	KIC Europe, MassBio	45/100
10th	Scilex Holding 2019, Palo Alto (United States), Public	Developer of non-opioid therapies for acute and chronic pain	-	Frazier Life Sciences	44/100
17th	QuadMedicine 2016, Seongnam-si (South Korea), Public	Provider of patch for vaccine delivery	$11.7M	NH Investment & Securities, Shinhan Venture Investment ... & 8 others	39/100